In 1999, Ventizileos et al. conducted a cost-effectiveness analysis comparing the determination of MS-AFP and ultrasound examination in detecting neural tube defects (NTDs) in the second trimester of pregnancy. The gene discussed is AFP; the disease is isolated spina bifida.